safinamide has been researched along with Myotonia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Altamura, C; Caccia, C; Carratù, MR; Conte, D; De Bellis, M; De Luca, A; Desaphy, JF; Farinato, A; Imbrici, P; Keywood, C; Melloni, E; Padoani, G; Pierno, S; Tarantino, N; Vailati, S | 1 |
1 other study(ies) available for safinamide and Myotonia
Article | Year |
---|---|
Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo.
Topics: Action Potentials; Alanine; Animals; Benzylamines; HEK293 Cells; Humans; Male; Muscle, Skeletal; Myotonia; NAV1.4 Voltage-Gated Sodium Channel; Rats; Rats, Wistar | 2020 |